This aligns with INTERHEART findings of increased myocardial infarction risk when apoB exceeds non‐HDL‐C,26 and ARIC findings that demonstrate higher ASCVD and CHD risk in individuals with low Lp(a) and high apoB.10 The gene discussed is LPA; the disease is myocardial infarction.